These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 15301157

  • 1. Cryopreserved rat, dog and monkey hepatocytes: measurement of drug metabolizing enzymes in suspensions and cultures.
    Hewitt NJ, Utesch D.
    Hum Exp Toxicol; 2004 Jun; 23(6):307-16. PubMed ID: 15301157
    [Abstract] [Full Text] [Related]

  • 2. Metabolic activity of fresh and cryopreserved cynomolgus monkey (Macaca fascicularis) hepatocytes.
    Hewitt NJ, Fischer T, Zuehlke U, Oesch F, Utesch D.
    Xenobiotica; 2000 Jul; 30(7):665-81. PubMed ID: 10963058
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of a cocktail of probe substrates for drug-metabolizing enzymes for the assessment of the metabolic capacity of hepatocyte preparations.
    Floby E, Briem S, Terelius Y, Sohlenius-Sternbeck AK.
    Xenobiotica; 2004 Jul; 34(11-12):949-59. PubMed ID: 15801540
    [Abstract] [Full Text] [Related]

  • 5. A comprehensive evaluation of metabolic activity and intrinsic clearance in suspensions and monolayer cultures of cryopreserved primary human hepatocytes.
    Smith CM, Nolan CK, Edwards MA, Hatfield JB, Stewart TW, Ferguson SS, Lecluyse EL, Sahi J.
    J Pharm Sci; 2012 Oct; 101(10):3989-4002. PubMed ID: 22806329
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Metabolic activity of fresh and cryopreserved dog hepatocyte suspensions.
    Swales NJ, Utesch D.
    Xenobiotica; 1998 Oct; 28(10):937-48. PubMed ID: 9849641
    [Abstract] [Full Text] [Related]

  • 8. Effect of honokiol on the induction of drug-metabolizing enzymes in human hepatocytes.
    Cho YY, Jeong HU, Kim JH, Lee HS.
    Drug Des Devel Ther; 2014 Oct; 8():2137-45. PubMed ID: 25395831
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cryopreservation of rat and mouse hepatocytes. I. Comparative viability studies.
    Swales NJ, Luong C, Caldwell J.
    Drug Metab Dispos; 1996 Nov; 24(11):1218-23. PubMed ID: 8937856
    [Abstract] [Full Text] [Related]

  • 11. Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential.
    Li AP, Lu C, Brent JA, Pham C, Fackett A, Ruegg CE, Silber PM.
    Chem Biol Interact; 1999 Jun 01; 121(1):17-35. PubMed ID: 10418968
    [Abstract] [Full Text] [Related]

  • 12. Studies comparing in vivo:in vitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte cultures.
    Hewitt NJ, Bühring KU, Dasenbrock J, Haunschild J, Ladstetter B, Utesch D.
    Drug Metab Dispos; 2001 Jul 01; 29(7):1042-50. PubMed ID: 11408372
    [Abstract] [Full Text] [Related]

  • 13. Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction.
    Hengstler JG, Utesch D, Steinberg P, Platt KL, Diener B, Ringel M, Swales N, Fischer T, Biefang K, Gerl M, Böttger T, Oesch F.
    Drug Metab Rev; 2000 Feb 01; 32(1):81-118. PubMed ID: 10711408
    [Abstract] [Full Text] [Related]

  • 14. Phase I and II metabolism and carbohydrate metabolism in cultured cryopreserved porcine hepatocytes.
    Loven AD, Olsen AK, Friis C, Andersen B.
    Chem Biol Interact; 2005 Jun 30; 155(1-2):21-30. PubMed ID: 15950209
    [Abstract] [Full Text] [Related]

  • 15. Use of isolated hepatocyte preparations for cytochrome P450 inhibition studies: comparison with microsomes for Ki determination.
    Brown HS, Chadwick A, Houston JB.
    Drug Metab Dispos; 2007 Nov 30; 35(11):2119-26. PubMed ID: 17724064
    [Abstract] [Full Text] [Related]

  • 16. Development of a novel in vitro model to predict hepatic clearance using fresh, cryopreserved, and sandwich-cultured hepatocytes.
    Lau YY, Sapidou E, Cui X, White RE, Cheng KC.
    Drug Metab Dispos; 2002 Dec 30; 30(12):1446-54. PubMed ID: 12433818
    [Abstract] [Full Text] [Related]

  • 17. Cryopreservation of rat and dog hepatocytes for studies of xenobiotic metabolism and activation.
    Powis G, Santone KS, Melder DC, Thomas L, Moore DJ, Wilke TJ.
    Drug Metab Dispos; 1987 Dec 30; 15(6):826-32. PubMed ID: 2893709
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures.
    Yokoyama Y, Sasaki Y, Terasaki N, Kawataki T, Takekawa K, Iwase Y, Shimizu T, Sanoh S, Ohta S.
    Biol Pharm Bull; 2018 May 01; 41(5):722-732. PubMed ID: 29445054
    [Abstract] [Full Text] [Related]

  • 20. A Novel In vitro Experimental System for the Evaluation of Enteric Drug Metabolism: Cofactor-Supplemented Permeabilized Cryopreserved Human Enterocytes (MetMax™ Cryopreserved Human Enterocytes).
    Li AP, Amaral K, Ho MD.
    Drug Metab Lett; 2018 May 01; 12(2):132-137. PubMed ID: 30124163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.